Notice of Board of Director and Corporate Auditor Nominations
May 9, 2024, Osaka, Japan - Santen Pharmaceutical Co., Ltd. (hereinafter Santen) announced today the nominations for the members of the Board of Directors and Corporate Auditors effective June 25, 2024, subject to approval at the 112th Annual General Meeting of Shareholders and the following Board of Directors meeting on June 25, 2024.
Members of the Board of Directors (As of June 25, 2024)
[Directors]
| Name | New position | Current position | |
|---|---|---|---|
| Reappointed | Akira Kurokawa | Director of the Board, Chairman | Director of the Board, Chairman |
| Takeshi Ito | Representative Director of the Board, President, Chief Executive Officer | Representative Director of the Board, President, Chief Executive Officer | |
| Noboru Kotani | Member of the Board* | Member of the Board* | |
| Tamie Minami | Member of the Board* | Member of the Board* | |
| Newly appointed | Rie Nakajima | Member of the Board, Corporate Officer Chief Operating Officer Head of China Business | Corporate Officer Chief Operating Officer Head of China Business |
| Ippei Kurihara | Member of the Board, Corporate Officer Head of Japan Business Global Commercial Strategy | Corporate Officer Head of Japan Business Global Commercial Strategy | |
| Masahiko Ikaga | Member of the Board* | Corporate Auditor** | |
| Minoru Kikuoka | Member of the Board* | --- | |
| Retirement | Kanoko Oishi | --- | Member of the Board* |
| Yutaro Shintaku | --- | Member of the Board* | |
| Kunihito Minakawa | --- | Member of the Board* |
*Outside Directors are independent officers as designated by the Tokyo Stock Exchange.
**Outside Corporate Auditors are independent officers designated by the Tokyo Stock Exchange.
[Corporate Auditors]
| Name | New position | Current position | |
|---|---|---|---|
| Reappointed | Hiroshi Isaka | Standing Corporate Auditor | Standing Corporate Auditor |
| Newly appointed | Yuichiro Munakata | Corporate Auditor* | --- |
| Retirement | Masahiko Ikaga | Member of the Board** | Corporate Auditor* |
*Outside Corporate Auditors are independent officers designated by the Tokyo Stock Exchange.
**Outside Directors are independent officers as designated by the Tokyo Stock Exchange.
Other Corporate Auditors (Junichi Asatani, Yaeko Hodaka) are within their tenure, not subjects for reelection this year.
About Santen
As a specialized company dedicated to eye health, Santen aspires to contribute to the realization of “Happiness with Vision” by providing products and services to patients, consumers, and medical professionals around the world. Since its establishment, and guided by its CORE PRINCIPLE, “Tenki ni sanyo suru,” Santen has been committed to helping people maintain and improve their eye health for more than 130 years. Santen is engaged in the global research and development, manufacturing, and sales and marketing of pharmaceutical products in the field of eye care, supporting the eye health of approximately 50 million people in more than 60 countries and regions worldwide. Santen’s mission is to provide essential and significant value to patients and society in the prevention, diagnosis, and treatment of eye diseases through products and services created from its expertise in the ophthalmology field and from the patient's perspective. To create a future in which as many patients as possible can lead happy and fulfilling lives, Santen is committed to doing its utmost to realize a society in which people around the world can experience “Happiness with Vision.”
For more information, please visit Santen’s website https://www.santen.com/en.
Contact
Corporate Communications
Santen Pharmaceutical Co., Ltd.
E-mail: communication@santen.com
Official SNS
